John Sharp

Track

Insider profile

Currently holds a position at PhaseBio Pharmaceuticals Inc

Performance

Overall performance
1.6
Performance over holding periods
1.6
30 days 90 days 120 days
Average return -9% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer PhaseBio Pharmaceuticals Inc None -
Chief Financial Officer, Vice President - Finance Ligand Pharmaceuticals Incorporated April 30, 2007 - Feb. 28, 2014
John Sharp's trades of PhaseBio Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
287.41
Quantity 78,402 -5.0%
Value US$2,572,498
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2018-12-11 2018-12-07
B Purchase
78,402 -5.0%
287.41
US$2,572,498 		78,402 -5.0% 287.41 US$2,572,498